Testing for epidermal growth factor receptor in lung cancer: Have we learned anything from HER-2 testing?

被引：5
|
作者：
Yaziji, H [1 ]
Gown, AM
机构：
[1] Baptist Hosp Miami, Miami, FL USA
[2] PhenoPath Labs, Seattle, WA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 17期
关键词：
D O I：
10.1200/JCO.2004.99.015
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3646 / 3646
页数：1
相关论文
共 50 条
  • [41] An inactive receptor for epidermal growth factor (EGFR) interacts with HER-2 to induce proliferation in cervical cancer cell lines
    Soto-Cruz, I.
    Valle-Mendiola, A.
    Martinez-Castro, J.
    Zerecero-Carreon, O.
    Bustos-Rodriguez, R.
    Weiss-Steider, B.
    FEBS JOURNAL, 2012, 279 : 184 - 184
  • [42] Identifying lung cancer patients who may be eligible for epidermal growth factor receptor (EGFR) mutation testing
    Hicks, Karalyn
    Wong, Conroy
    NEW ZEALAND MEDICAL JOURNAL, 2013, 126 (1381) : 49 - 56
  • [43] FREQUENCY AND SPECTRUM OF EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) MUTATIONS IN LUNG CANCER IN AN AUSTRALIAN TESTING PROGRAM.
    Solomon, B.
    Peters, M.
    Bowden, J.
    Lewis, J.
    Carpenter, P.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : S183 - S184
  • [44] Human Epidermal Growth Factor Receptor 2 Testing in Primary Breast Cancer in the Era of Standardized Testing: A Canadian Prospective Study
    Hanna, Wedad M.
    Barnes, Penny J.
    Chang, Martin C.
    Gilks, C. Blake
    Magliocco, Anthony M.
    Rees, Henrike
    Quenneville, Louise
    Robertson, Susan J.
    SenGupta, Sandip K.
    Nofech-Mozes, Sharon
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (35) : 3967 - 3973
  • [45] Human epidermal growth factor receptor 2 (HER2) in gastric cancer (GC): results of the ToGA trial screening programme and recommendations for HER2 testing
    Chung, H.
    Bang, Y. J.
    Xu, J. M.
    Lordick, F.
    Sawaki, A.
    Lipatov, O.
    Lehle, M.
    Pickl, M.
    Rueschoff, J.
    Van Cutsem, E.
    EJC SUPPLEMENTS, 2009, 7 (02): : 364 - 364
  • [46] UTILITY OF TESTING FOR NON-SMALL CELL LUNG CANCER (NSCLC) EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) MUTATIONS IN AN AUSTRALIAN TESTING PROGRAM
    Peters, M.
    Solomon, B.
    Bowden, J.
    Lewis, J.
    Carpenter, P.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : S180 - S180
  • [47] Cyclooxygenase-2 (COX-2), epidermal growth factor receptor (EGFR), and Her-2/neu expression in ovarian cancer
    Ferrandina, G
    Ranelletti, FO
    Lauriola, L
    Fanfani, F
    Legge, F
    Mottolese, M
    Nicotra, MR
    Natali, PG
    Zakut, VH
    Scambia, G
    GYNECOLOGIC ONCOLOGY, 2002, 85 (02) : 305 - 310
  • [48] Human epidermal growth factor (Her-2) in gastric and colorectal adenocarcinoma
    Shabbir, Asma
    Qureshi, Muhammad Asif
    Mirza, Talat
    Bin Khalid, Abdullah
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2017, 67 (07) : 1085 - 1090
  • [49] Expression of the epidermal growth factor receptors (EGFR and HER-2) in esophageal squamous cell cancer
    Delektorskaya, V. V.
    Jurievna, Chemeris G.
    Kononec, V. P.
    Grigorchuk, Ju. A.
    VIRCHOWS ARCHIV, 2009, 455 : 137 - 137
  • [50] Breast cancer in Brazil: HER-2 testing and treatment patterns
    Palacio, Sofia
    Torres, Alfredo
    Prado, Edna
    Lopes, Gilberto
    CANCER RESEARCH, 2018, 78 (04)
12345